An Open Label, Multi-Centre Study to Determine the Safety and Efficacy of STC3141 Administered as an Infusion for up to 5 days in Subjects with COVID-19 Acute Respiratory Distress Syndrome Requiring Intensive Care

  • Al-Bassam, Wisam (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date12/11/20 → 11/11/25

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • COVID-19
  • intensive care